Search for: "Pfizer Pharmaceutic, Inc." Results 481 - 500 of 667
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2021, 3:30 am by Liz Dunshee
Here’s an excerpt from yesterday’s SEC complaint: – On August 18, 2016, and in the course of Panuwat’s employment at Medivation, Panuwat received confidential, nonpublic information in an email from Medivation’s Chief Executive Officer (“CEO”) that Medivation would be imminently acquired by pharmaceutical giant Pfizer, Inc. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi… [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
11 Nov 2009, 11:54 am
Now, four years after that decision gave Susette Kelo's land to private developers for a project including a hotel and offices intended to enhance Pfizer Inc.'s nearby corporate facility, the pharmaceutical giant has announced it will close its research and development headquarters in New London, Connecticut. [read post]
4 Aug 2010, 4:30 am by Laura Simons
According to a 2008 article in The New York Times, Pfizer Inc., the maker of Zoloft, called the case "tragic" but said, "Zoloft didn't cause his problems, nor did the medication drive him to commit murder. [read post]
21 Nov 2007, 4:08 am
Teva Pharmaceuticals); regarding (1), the court stated that "Canon has established a substantial likelihoodâ€â [read post]
29 Aug 2011, 7:56 am by Sonya Hubbard
Prior to that, he spent 17 years with Warner-Lambert, which is now part of Pfizer, Inc. [read post]
3 Aug 2011, 5:11 am by Lawrence B. Ebert
Related to Merck's large layoff, the Newark Star-Ledger noted that New Jersey's Department of Labor and Workforce Development schedules events at companies that announce large downsizings to teach employees how to access unemployment insurance and explore other employment optionsOn July 21, 2011: Merck & Co., Inc., Whitehouse Station, N.J., , acting through an affiliate and known as MSD outside the United States and Canada, and China's Simcere Pharmaceutical… [read post]
9 Apr 2007, 7:30 am
Robert Temple, director of the FDA's Offices of Drug Evaluation, said his agency is "not particularly worried" about Dostinex:The two studies, published in January in the New England Journal of Medicine, also tied another Parkinson's drug, Pfizer Inc.'s Dostinex, or cabergoline, to heart-valve problems. [read post]
15 Jan 2010, 10:39 am by Hopkins
So, for all of you who are health advocates for your significant pets, the recalled drugs include: Ketamine: Ketaset (Fort Dodge/Pfizer) KetaVed (VEDCO), KetaThesia (Butler) VetaKet (LLOYD Laboratories) Ketaject (Phoenix) Keta-Sthetic (RVX) AmTech Group, Inc. [read post]
18 Jan 2007, 6:23 am
Most innovative use of technology in a law dept: John Theriault, vice president, and Mary Ann Sarao, director, global security of Pfizer Inc. [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
(now part of Pfizer, Inc.),  also sought government permission to put out its own generic version of K-Dur. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
26 Jan 2015, 4:00 am by Kimberly A. Kralowec
Pfizer, Inc. (2010) 49 Cal.4th 758 in which the Supreme Court held retail pharmacies had standing to assert UCL claims against pharmaceutical companies that had allegedly engaged in price fixing even though the retail pharmacies were able to pass on any overcharges to their customers. [read post]
3 Aug 2011, 3:31 am by Marie Louise
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]